Delivery Order SPE2DB22D9362-SPE2DB23FT0BZ
Award Date 7/27/23
Potential Completion Date 8/17/23
Potential Value $4.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DOD) awarded a $6,189.60 firm fixed price delivery order contract to DMS Pharmaceutical Group Inc. for the product XOLAIR 150 MG/ML SYRINGEML. The place of performance will be in Park Ridge, Illinois. The start date is September 6, 2023 and the end date is September 27, 2023. No set aside designation or subcontractors were identified. The DLA supports the military services by providing supplies in support of readiness and contingency operations, so this contract for...
- The Defense Logistics Agency (DOD) awarded a $3,094.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 27, 2023 through August 17, 2023. No major subcontractors or set aside designations were identified. The DLA supports military readiness by providing supplies to the armed forces, so this contract is likely for pharmaceutical...
- The Defense Logistics Agency (DOD) awarded a $3,094.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the purchase of XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from August 29, 2023 through September 20, 2023. No set aside designation or subcontractors were identified. The DLA supports military readiness by procuring and providing supplies, equipment, and weapon systems for the armed forces and other government...
- The Defense Logistics Agency (DOD) awarded a $4,642.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML" under contract number 4561610732. Place of performance will be in Park Ridge, Illinois, with work scheduled to be completed by August 11, 2023 after starting on July 21st of this year. No set aside designation or subcontractors were indicated. DLA supports military readiness by procuring and providing logistics support...
- The Defense Logistics Agency (DOD) awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from June 28, 2023 through July 20, 2023. As the DLA supports the logistical needs of the military services, this contract will likely deliver the pharmaceutical product to DOD medical treatment facilities and personnel within the...
- The Defense Logistics Agency (DOD) awarded a $92,844 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between July 10-31, 2023. DLA manages the military's supply chain and procurement programs, likely utilizing this contract to supply allergy medication to military treatment facilities. No set aside designation or subcontractors were indicated. The short period of performance...
- The Defense Logistics Agency (DOD) awarded a $5,415.90 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 25, 2023 through August 15, 2023. No set aside designation or subcontractors were identified. The DLA supports the Department of Defense by providing supplies in support of readiness and contingency operations. This delivery...
- The Defense Logistics Agency (DOD) awarded a $77,370 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for XOLAIR 150 MG/ML SYRINGEML. The place of performance is Park Ridge, Illinois. The period of performance is from September 5, 2023 through September 26, 2023. As the DLA supports the logistical needs of the military services, this delivery order is likely providing a pharmaceutical product in support of DOD medical readiness programs over the three week period of...
- The Defense Logistics Agency (DOD) awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is July 25, 2023 through August 15, 2023. No set aside designation or subcontractors were identified. The DLA supports the Department of Defense by providing supplies in support of readiness and contingency operations. This delivery...
- The Defense Logistics Agency, a combat support agency within the Department of Defense, awarded a $46,513.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois, and the period of performance is from September 29, 2023 through October 23, 2023. As the DLA supports military operations by providing food, fuel, repair parts and other supplies, this delivery order is likely...
- SPE2DB22D9362Indefinite Delivery Contract
- SPE2DB22D9362-SPE2DB23FT0BZDelivery Order
The Defense Logistics Agency (DOD) awarded a $4,642.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML" under contract number 4561678775. Performance will take place in Park Ridge, Illinois over a three week period concluding on August 17, 2023. As the DLA supports the military services by providing nearly 100% of the consumable items needed to equip America's warfighters, this contract for allergy medication will help the Agency maintain readiness by ensuring service members have access to necessary pharmaceuticals. No subcontractors or set aside designations were indicated.
Generated 12/20/23, 5:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/27/23 |